These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35152500)

  • 1. Immunoglobulin replacement therapy in chronic lymphocytic leukaemia patients with hypogammaglobulinaemia and infection.
    Keegan A; Dennington PM; Dhondy N; Mulligan SP
    Eur J Haematol; 2022 Jun; 108(6):460-468. PubMed ID: 35152500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin replacement in chronic lymphocytic leukaemia.
    Bunch C
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):419-22. PubMed ID: 3065737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immune globulin in chronic lymphocytic leukaemia.
    Gamm H; Huber C; Chapel H; Lee M; Ries F; Dicato MA
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):17-20. PubMed ID: 8033428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia.
    Boughton BJ; Jackson N; Lim S; Smith N
    Clin Lab Haematol; 1995 Mar; 17(1):75-80. PubMed ID: 7621634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency.
    Visentin A; Molinari MC; Pravato S; Cellini A; Angotzi F; Cavaretta CA; Ruocco V; Imbergamo S; Piazza F; Proietti G; Mauro FR; Trentin L
    Curr Oncol; 2022 Dec; 30(1):274-283. PubMed ID: 36661671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hypogammaglobulinaemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin.
    Jurlander J; Geisler CH; Hansen MM
    Eur J Haematol; 1994 Aug; 53(2):114-8. PubMed ID: 8088382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
    Noto A; Cassin R; Mattiello V; Bortolotti M; Reda G; Barcellini W
    Front Immunol; 2023; 14():1062376. PubMed ID: 37122737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG testing, immunoglobulin replacement therapy, and infection outcomes in patients with CLL or NHL: real-world evidence.
    Soumerai JD; Yousif Z; Gift T; Desai R; Huynh L; Ye M; Banatwala A; Clear L; Pinaire M; Belsky G; Hsieh YG; Herrick C; Darnell EP; Duh MS; Sanchirico M; Murphy SN
    Blood Adv; 2024 Aug; 8(16):4239-4249. PubMed ID: 38904477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlations between secondary hypogammaglobulinaemia, infections and mortality and the need for preventive immunoglobulin replacement in patients with chronic lymphoid leukaemia].
    Losonczy H; Nagy Á; Kosztolányi S; Tóth O; Csalódi R; Hussain A; Szomor Á
    Orv Hetil; 2019 Sep; 160(38):1487-1494. PubMed ID: 31537095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in intravenous immunoglobulin use in New South Wales, Australia.
    Wood JG; Heywood AE; Dennington PM; Lloyd AR; Ziegler JB
    Intern Med J; 2024 Jan; 54(1):149-156. PubMed ID: 37488980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin replacement in patients with chronic lymphocytic leukemia (CLL): kinetics of immunoglobulin metabolism.
    Chapel HM; Lee M
    J Clin Immunol; 1992 Jan; 12(1):17-20. PubMed ID: 1551938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usage of intravenous immunoglobulins in Auckland.
    Lee YC; Woodfield DG; Douglas R
    N Z Med J; 1998 Feb; 111(1060):48-50. PubMed ID: 9539915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing hypogammaglobulinaemia secondary to haematological malignancies in Australia and New Zealand: a clinician survey.
    Wong J; Wood EM; Crispin P; Weinkove R; McQuilten ZK;
    Intern Med J; 2019 Mar; 49(3):358-363. PubMed ID: 30129248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypogammaglobulinaemia in low grade B cell tumours; significance and therapy.
    Chapel H; Griffiths H; Brennan V; Bunch C; Lea J; Lee M
    Immunol Invest; 1991 Apr; 20(2):187-91. PubMed ID: 1864637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous and subcutaneous immunoglobulin therapy].
    Thon V
    Epidemiol Mikrobiol Imunol; 2013 Jul; 62(2):64-73. PubMed ID: 23964967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.
    Suri D; Bhattad S; Sharma A; Gupta A; Rawat A; Sehgal S; Singh S; Gupta S
    J Clin Immunol; 2017 Apr; 37(3):311-318. PubMed ID: 28321612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients.
    Quartier P; Debré M; De Blic J; de Sauverzac R; Sayegh N; Jabado N; Haddad E; Blanche S; Casanova JL; Smith CI; Le Deist F; de Saint Basile G; Fischer A
    J Pediatr; 1999 May; 134(5):589-96. PubMed ID: 10228295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registry.
    Abadeh A; Shehadeh S; Betschel S; Waserman S; Cameron DW; Cowan J
    PLoS One; 2023; 18(11):e0294408. PubMed ID: 37971974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study.
    Molica S; Musto P; Chiurazzi F; Specchia G; Brugiatelli M; Cicoira L; Levato D; Nobile F; Carotenuto M; Liso V; Rotoli B
    Haematologica; 1996; 81(2):121-6. PubMed ID: 8641639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections.
    Günther G; Dreger B
    Microbiol Immunol; 2013 Jul; 57(7):527-35. PubMed ID: 23607863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.